Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling.

Citation:
SA, I., H. H, V. L,, Jouini R, and et al, "Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling.", PLoS One, vol. 8(12):e85737. , 2013.
Tourism